Hereditary optic neuropathy treatment of Leber and dominant optic atrophy with tocotrienol quinones

摘要

A composition for use in the treatment, prevention or improvement of dominant optic atrophy (DOA) in an individual suffering from dominant optic atrophy (DOA), said composition comprising a therapeutically effective amount of a compound selected from the group consisting of in tocotrienol quinones and tocotrienol hydroquinones.